IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Farina, Mirko
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.280
EU - Europa 683
AS - Asia 285
OC - Oceania 9
SA - Sud America 9
AF - Africa 1
Totale 2.267
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.268
IT - Italia 286
CN - Cina 112
HK - Hong Kong 110
UA - Ucraina 96
FI - Finlandia 82
DE - Germania 69
IE - Irlanda 43
GB - Regno Unito 36
SG - Singapore 26
SE - Svezia 24
FR - Francia 23
IN - India 18
BE - Belgio 10
CA - Canada 10
AU - Australia 9
TR - Turchia 6
AT - Austria 5
GR - Grecia 4
BR - Brasile 3
CO - Colombia 3
JP - Giappone 3
MY - Malesia 2
PE - Perù 2
RU - Federazione Russa 2
TH - Thailandia 2
BO - Bolivia 1
CZ - Repubblica Ceca 1
IR - Iran 1
KR - Corea 1
LK - Sri Lanka 1
LV - Lettonia 1
MS - Montserrat 1
MU - Mauritius 1
NL - Olanda 1
PA - Panama 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 2.267
Salva come PNG Salva come JPEG
Città #
Fairfield 181
Chandler 119
Hong Kong 110
Ashburn 101
Woodbridge 92
Wilmington 82
Jacksonville 78
Helsinki 76
New York 73
Princeton 70
Seattle 70
Brescia 65
Houston 63
Cambridge 45
Dublin 41
Ann Arbor 35
Shanghai 33
Beijing 24
Pune 14
San Diego 14
Des Moines 13
Milan 13
Barlassina 12
London 11
Nanjing 11
Rome 11
Brussels 10
Dearborn 9
Jinan 9
Nanchang 9
Genoa 6
Toronto 6
Bologna 5
Kocaeli 5
Philadelphia 5
San Francisco 5
Shenyang 5
Tianjin 5
Vienna 5
Athens 4
Battipaglia 4
Bergamo 4
Cagliari 4
Chiswick 4
Darfo 4
Hebei 4
Lappeenranta 4
Pescara 4
Singapore 4
Sydney 4
Turin 4
Alzano Lombardo 3
Brendola 3
Chiari 3
Chicago 3
Como 3
Florence 3
Los Angeles 3
Norwalk 3
Padova 3
São Paulo 3
Viterbo 3
Ancona 2
Augusta 2
Birmingham 2
Bucaramanga 2
Casanova Lonati 2
Castleknock 2
Cetraro 2
Corte Franca 2
Halifax 2
Hamburg 2
Hounslow 2
Lima 2
Lovere 2
Mazzano 2
Melbourne 2
Mumbai 2
Ningbo 2
Perth 2
Rockville 2
Salt Lake City 2
Shah Alam 2
Storo 2
Tokyo 2
Torre Boldone 2
Treviglio 2
Verona 2
Vicenza 2
Acton 1
Adelaide 1
Alessandria 1
Aosta 1
Bangkok 1
Baotou 1
Boardman 1
Bogotá 1
Borås 1
Boston 1
Brooklyn 1
Totale 1.687
Salva come PNG Salva come JPEG
Nome #
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 112
Is Having Clonal Cytogenetic Abnormalities the Same as Having Leukaemia 104
Prognostic role of baseline 18F-FDG PET/CT parameters in MALT lymphoma 102
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 100
A Gene Panel NGS-Based Strategy for Genomic Characterization of Acute Myeloid Leukemias (AMLs) 93
First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response 93
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 93
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 76
ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial 73
Advances in CMV Management: A Single Center Real-Life Experience 72
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors and Circulating Endothelial Cells in Patients With Primary Myelofibrosis 66
Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms 65
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 64
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 62
OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 57
Identification of Relapse Risk Using a Multiparameter Flow Cytometry-Based Detection of Minimal Residual Disease in Adult Patients with Acute Myeloid Leukemia at ELN Intermediate-Risk 54
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 52
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 52
POST REMISSION SEQUENTIAL MONITORING OF MINIMAL RESIDUAL DISEASE BY WT1 Q-PCR AND MULTIPARAMETRIC FLOW CYTOMETRY PREDICTS RELAPSE AND MAY HELP TO ADDRESS THE RISK ADAPTED THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS 51
Comparative monitoring of deep molecular response (DMR) by RT-quantitative (RT-qPCR) and digital PCR (dPCR) in Ph+ Chronic Myeloid Leukemia (CML) patients treated with TKIs for recognition of stable deep molecular response (DMR) and identification of best candidates to TKIs treatment discontinuation. 51
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 44
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 43
dsDNA from extracellular vesicles (EVs) in adult AML 41
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 40
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 40
Comparative Mutational Profiling of Hematopoietic Progenitor Cells and Circulating Endothelial Cells (CECs) in Patients with Primary Myelofibrosis 39
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 38
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey) 38
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 36
PS1540 MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT) 35
Exosomes and Extracellular Vesicles in Myeloid Neoplasia: The Multiple and Complex Roles Played by These “Magic Bullets” 32
PF688 JAK2 ALLELIC RATIO IMPACTS ON VASCULAR EVENT IN MYELOFIBROSIS BY INCREASING THE RISK OF THROMBOSIS. A SINGLE CENTER EXPERIENCE ON 150 PATIENTS 30
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 27
S882 OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 27
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 25
How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation 24
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 22
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study 22
Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors 19
Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia 18
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 17
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 17
Successful CAR-T cell therapy in a refractory MCL patient with bacterial, fungal and COVID-19 infection: a case report 15
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 14
The possible role of mutated endothelial cells in myeloproliferative neoplasms 13
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 11
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR) 11
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 10
Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients 10
Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration 9
Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study 9
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 9
PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY 9
Pre-Emptive Donor Lymphocyte Infusion As Optimal Treatment for Relapsed Acute Myeloid Leukemias and Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation: Insights from a French-Italian Study on 134 Patients 7
Digital PCR as a New Method for Minimal Residual Disease Monitoring and Treatment Free Remission Management in Chronic Myeloid Leukemia Patients: Is It Reliable? 7
MALNUTRITION AND GVHD IN ALLOGENIC BONE MARROW TRANSPLANTATION: A PROSPECTIVE STUDY 6
3-YEARS and Beyond Study Completion Results of the Otpkima Randomized Clinical Trial in Elderly CML Patients 6
Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor? 5
The e13a2 BCR-ABL transcript negatively affects sustained deep molecular response and the achievement of treatment-free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors 5
S157: BCR::ABL1 DIGITAL PCR IDENTIFIES CHRONIC PHASE CML PATIENTS SUITABLE FOR AN EARLY TKI DISCONTINUATION ATTEMPT: A PATIENT-LEVEL META-ANALYSIS 5
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis 5
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation (Bone Marrow Transplantation, (2023), 10.1038/s41409-023-02124-y) 5
Nutritional strategies to improve VRE control 5
Adult onset hemophagocytic lymphohistiocytosis prognosis is affected by underlying disease and coexisting viral infection: analysis of a single institution series of 35 patients 4
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan 4
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study 3
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study 3
Twenty years of evolution of CML therapy: how the treatment goal is moving from disease to patient 3
Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms 1
Totale 2.360
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.626
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201927 0 0 0 0 0 0 0 0 0 0 14 13
2019/2020302 20 4 5 11 17 34 29 34 42 60 16 30
2020/2021492 11 25 13 67 29 63 29 55 47 86 34 33
2021/2022365 22 15 12 44 13 21 19 40 24 49 22 84
2022/2023452 46 12 19 41 33 91 2 53 55 11 36 53
2023/2024638 31 23 58 53 60 156 43 45 137 27 5 0
Totale 2.360